Correlation Between Bio Path and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Path and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Lipocine, you can compare the effects of market volatilities on Bio Path and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Lipocine.

Diversification Opportunities for Bio Path and Lipocine

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Bio and Lipocine is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Bio Path i.e., Bio Path and Lipocine go up and down completely randomly.

Pair Corralation between Bio Path and Lipocine

Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Lipocine. But the stock apears to be less risky and, when comparing its historical volatility, Bio Path Holdings is 1.25 times less risky than Lipocine. The stock trades about -0.25 of its potential returns per unit of risk. The Lipocine is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  555.00  in Lipocine on August 29, 2024 and sell it today you would lose (113.00) from holding Lipocine or give up 20.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bio Path Holdings  vs.  Lipocine

 Performance 
       Timeline  
Bio Path Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Lipocine 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Bio Path and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Path and Lipocine

The main advantage of trading using opposite Bio Path and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind Bio Path Holdings and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation